Development and validation of novel automatable assay for cholesterol efflux capacity

During the past decade, evaluation of high-density lipoprotein (HDL) functionality has been well studied for predicting cardiovascular disease (CVD) risk. Cholesterol efflux capacity (CEC) is the strongest candidate as the biomarker out of various HDL antiatherosclerotic functions. However, CEC has...

Descripción completa

Detalles Bibliográficos
Autores principales: Mutsuda, Yume, Miyakoshi, Tsunehiro, Horiuchi, Yuna, Kameda, Takahiro, Tozuka, Minoru, Ohkawa, Ryunosuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2023
Materias:
Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905788/
https://www.ncbi.nlm.nih.gov/pubmed/36645426
http://dx.doi.org/10.1042/BSR20221519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905788/
https://www.ncbi.nlm.nih.gov/pubmed/36645426
http://dx.doi.org/10.1042/BSR20221519

Ejemplares similares